Lufax CEO discloses 500,000 share option holdings

Lufax Holding Ltd director and Chief Executive Officer Cho Yong Suk filed an initial ownership report showing existing stock option holdings.

Accepted by SEC EDGAR 03/18/2026 - 09:03 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Lufax Holding Ltd director and Chief Executive Officer Cho Yong Suk filed an initial ownership report showing existing stock option holdings. He holds stock options to buy 100,000 Ordinary Shares at an exercise price of 15.14 expiring on April 8, 2026, and additional options to buy 400,000 Ordinary Shares at an exercise price of 18.06 expiring on December 29, 2027, all held directly.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Cho Yong Suk

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Holding	Stock Options (right to buy)	--	--	--
Holding	Stock Options (right to buy)	--	--	--

Holdings: Stock Options (right to buy) — 500,000 contracts (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Lufax (LU) Form 3 filing by CEO Cho Yong Suk show?

The Form 3 shows CEO and director Cho Yong Suk’s existing stock option holdings in Lufax Holding Ltd. It lists two option grants over Ordinary Shares, including exercise prices, share amounts, expiration dates, and that the positions are held directly rather than through another entity.

How many Lufax (LU) shares can CEO Cho Yong Suk buy under his options?

Cho Yong Suk holds options over a total of 500,000 Lufax Ordinary Shares. These consist of options for 100,000 shares at an exercise price of 15.14 and options for 400,000 shares at an exercise price of 18.06, all reported as directly owned.

What are the exercise prices and expiration dates of Lufax CEO Cho Yong Suk’s options?

One option grant allows purchase of 100,000 Ordinary Shares at 15.14, expiring on April 8, 2026. A second grant covers 400,000 Ordinary Shares at 18.06, expiring on December 29, 2027. Both positions are reported in the Form 3 as directly held.

Is Lufax (LU) CEO Cho Yong Suk buying or selling stock in this Form 3?

The Form 3 does not report new purchases or sales; it records existing holdings. It lists two stock option awards over Lufax Ordinary Shares as of the reporting date, classifying them as holdings rather than new transactions or open-market trades.

What type of securities are disclosed in Lufax (LU) CEO Cho Yong Suk’s Form 3?

The filing discloses derivative securities described as “Stock Options (right to buy).” Each option is linked to Lufax Ordinary Shares, with underlying amounts of 100,000 and 400,000 shares respectively, along with their specific exercise prices and expiration dates.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Cho Yong Suk

(Last) (First) (Middle)

TOWER A, SHANGHAI PING AN BUILDING,

NO. 206 KAIBIN ROAD, XUHUI DISTRICT

(Street)

SHANGHAI 200032

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Lufax Holding Ltd [ LU ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (right to buy)	04/30/2021	04/08/2026	Ordinary Shares	100,000	$15.14	D
Stock Options (right to buy)	12/29/2021	12/29/2027	Ordinary Shares	400,000	$18.06	D

Explanation of Responses:

	/s/ Yong Suk Cho	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)